Kazimierz Ciechanowski
Overview
Explore the profile of Kazimierz Ciechanowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Turon-Skrzypinska A, Tomska N, Mosiejczuk H, Ryl A, Szylinska A, Marchelek-Mysliwiec M, et al.
Sci Rep
. 2023 Aug;
13(1):12435.
PMID: 37528161
Renal replacement therapy is associated with reduced physical activity. The aim of the study was to assess the relationship between regular physical activity performed with the use of virtual reality...
12.
Bogacka A, Sobczak-Czynsz A, Balejko E, Heberlej A, Ciechanowski K
Nutrients
. 2023 Jan;
15(1).
PMID: 36615736
Loss of vitamin C, especially in conjunction with an inadequate supply, can lead to decreased plasma concentrations of vitamin C. This in turn can lead to overt or subclinical deficiency....
13.
Feret W, Safranow K, Kwiatkowska E, Daniel A, Ciechanowski K
Nutrients
. 2022 Dec;
14(24).
PMID: 36558477
Background: Hemodialyzed patients with poor erythropoietin response tend to have low volume of visceral adipose tissue and score high on malnutrition-inflammation score. This study investigates in-depth the role of leptin...
14.
Wojciuk B, Bogucka A, Czaplewska P, Okulewicz P, Wojciechowska-Koszko I, Ciechanowski K, et al.
Clin Transl Sci
. 2022 Nov;
16(1):118-127.
PMID: 36366854
Kidney transplantation remains the therapeutic option for patients with end-stage kidney disease. Current immunosuppressive regimens are efficient in combating acute kidney rejection. However, insights into chronic kidney allograft injury remains...
15.
Kwiatkowska E, Ciechanowski K, Domanski L, Dziedziejko V, Przybycinski J, Pawlik A
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359380
Tacrolimus, in combination with mycophenolate mofetil and glucocorticoids, is the basis of immunosuppressive therapy after renal transplantation. Tacrolimus intrapatient variability (IPV) and the blood concentration normalized by the dose (concentration/dose...
16.
Feret W, Nalewajska M, Ciechanowski K
Prz Gastroenterol
. 2022 Sep;
17(3):248-249.
PMID: 36127937
No abstract available.
17.
Surowka A, Szumilas K, Wilk A, Misiakiewicz-Has K, Ciechanowski K, Kedzierska-Kapuza K
Int J Environ Res Public Health
. 2022 Jun;
19(11).
PMID: 35681984
Immunosuppressive drugs are widely and chronically used to avoid graft rejection in transplant recipients. However, they are also known to have organotoxic effects and can exert numerous side effects. The...
18.
Wojciuk B, Majewska K, Grygorcewicz B, Krukowska Z, Kwiatkowska E, Ciechanowski K, et al.
PLoS One
. 2022 May;
17(5):e0268243.
PMID: 35604916
Background: Urinary tract infections (UTI) represent one of the most common contagious diseases in humans. Uropathogenic Escherichia coli (UPEC) strains are recognized as the most frequent causative agent, and these...
19.
Feret W, Safranow K, Ciechanowski K, Kwiatkowska E
J Clin Med
. 2022 May;
11(9).
PMID: 35566552
Background: Anemia is the most common finding in patients with end-stage kidney disease undergoing renal replacement therapy. A certain percentage of patients does not respond adequately to erythropoietin (EPO) treatment,...
20.
Kwiatkowska E, Safranow K, Wojciechowska-Koszko I, Roszkowska P, Dziedziejko V, Myslak M, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327438
Background/aims: Chronic kidney disease CKD patients on intermittent hemodialysis IHD are exposed to SARS-CoV-2 infection and carry a risk of developing severe symptoms. The aim of this study was to...